WAYLAND, Mass.--(BUSINESS WIRE)--Candela Corporation (NASDAQ:CLZR) today announced that it received an additional FDA clearance for the Serenity™ device using Pneumatic Skin Flattening (PSF™) technology. This clearance enables the use of the Serenity™ device for the reduction of pain during all laser and intense pulse light (IPL) treatments. According to Millennium Research, the worldwide installed base of laser and IPLs is estimated to be 70,000 worldwide.
